Penumbra (NYSE:PEN) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference
Penumbra (NYSE:PEN) is now covered by analysts at Wells Fargo & Company. They set an "underweight" rating and a $15.00 price target on the stock.
Penumbra Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand [Yahoo! Finance]
Penumbra (NYSE:PEN) had its price target raised by analysts at JPMorgan Chase & Co. from $265.00 to $275.00. They now have a "neutral" rating on the stock.